90 patents
Page 2 of 5
Utility
Methods Of Vaccine Administration
16 Mar 23
This invention relates to a method of treating a dog for canine diseases comprising administering to the dog therapeutically effective amounts of a vaccine, wherein the vaccine comprises viral antigens, a bacterin, or both, and wherein the vaccine is administered subcutaneously or orally according to the schedules provided herein.
Cassius McAllister Tucker, John David Haworth
Filed: 14 Nov 22
Utility
Serotonin 5-HT2B Inhibitory Compounds
9 Mar 23
Richard A. Ewin, Ashley E. Fenwick, Govindan Subramanian
Filed: 22 Jul 22
Utility
Recombinant Herpesvirus of Turkey Vectors Expressing Antigens of Avian Pathogens and Uses Thereof
29 Dec 22
The invention relates to recombinant viral vectors for the insertion and expression of foreign genes for use in safe immunizations to protect against a variety of pathogens.
Sing RONG, Yugang LUO, Tyler BROWN
Filed: 31 Aug 22
Utility
Method of Determining the Identity And/or Amount of an ANTI-IL-31 Antibody In a Sample
17 Nov 22
The present invention provides a method of determining the identity and/or amount of an anti-IL-31 antibody in a sample.
Gary Francis Bammert, Steven Alan Dunham
Filed: 28 Jul 22
Utility
Ehrlichia Vaccines and Immunogenic Compositions
10 Nov 22
Provided herein are immunogenic compositions that may be used, in some aspects, to induce an immune response against an Ehrlichia such as Ehrlichia cams.
Jere W. McBRIDE, Paul J. DOMINOWSKI, Suman MAHAN, Jason J. MILLERSHIP, Duncan M. MWANGI, Sharath RAI, Sharon M. WAPPEL
Filed: 13 Jul 20
Utility
Medicament Delivery System, and Associated Method
20 Oct 22
An intra-orifice medicament delivery system and formation method involve a housing defining an inner chamber extending along a longitudinal axis, with the chamber wall defining one or more openings therethrough.
Susan Leers Sucheta, Nicholas Alan Wicks, Derrick Scott Sjodin, Christopher Jeremy Block, Laibin Luo
Filed: 17 Feb 22
Utility
Endoparasitic Depsipeptides
13 Oct 22
Todd Maddux, Matthew W. Bedore, Paul D. Johnson, Tomasz Respondek, Susan M.K. Sheehan, Graham M. Kyne, Richard A. Ewin, Rajendran Vairagoundar, Michael P. Curtis
Filed: 7 May 19
Utility
North American Porcine Reproductive and Respiratory Syndrome (PRRS) Virus and Uses Thereof
29 Sep 22
The invention provides isolated polynucleotide molecules that comprise a DNA sequence encoding an infectious RNA sequence encoding a genetically-modified North American PRRS virus, methods to make it and related polypeptides, polynucleotides, and various components.
Jay Gregory CALVERT, David Ewell SLADE, Siao-Kun W. WELCH
Filed: 6 Jun 22
Utility
Mycoplasma Bovis Compositions
22 Sep 22
Disclosed herein are Mycoplasma bovis immunogenic compositions useful in raising an immune response in animals against M. bovis.
Glenn Francis Browning, Philip Francis Markham, Marc Serge Marenda, Fred H. Weber, Suman Mahan
Filed: 6 Jun 22
Utility
Effective Vaccination Against Porcine Reproductive and Respiratory Syndrome (PRRS) Virus Prior to Weaning
22 Sep 22
The invention provides isolated polynucleotide molecules that comprise a DNA sequence encoding an infectious RNA sequence encoding a genetically-modified North American PRRS virus, methods to make it and related polypeptides, polynucleotides, and various components.
Jay Gregory Calvert, Robert G. Ankenbauer, Jacqueline Gayle Marx, Douglas S. Pearce, Marcia L. Keith
Filed: 6 Jun 22
Utility
Horse IL-31 Induced Pruritus Model
1 Sep 22
The present invention provides an IL-31 horse pruritus model which confirms that IL-31 induces itch in horses and can be used to assess whether certain test compounds can block or reduce the itch in treated horses.
Elizabeth A. VanBeelen, Andrea J. Gonzales, Timothy J. Fleck, Katelyn S. Vroman, Gary F. Bammert
Filed: 18 Feb 22
Utility
Antibodies to Canine and Feline Oncostatin M Receptor Beta and Uses Thereof
9 Jun 22
The invention provides an isolated antibody, or antigen-binding portion thereof that specifically binds to canine or feline Oncostatin M receptor Beta (OSMR-β) or both, wherein the antibody antagonizes IL-31-mediated signaling or OSM-mediated signaling or both in a canine and/or feline cell.
Gary Francis Bammert, Andrea Joy Gonzales
Filed: 18 Oct 21
Utility
Vaccine Against Infectious Bronchitis
9 Jun 22
Poultry vaccines against infectious bronchitis and Turkey Rhinotracheitis are provided.
Carla Maria Batista de Freitas, Maria Carolina Ferreira dos Santos, Paul Joseph Dominowski, Harmen Jacob Geerligs
Filed: 13 Jul 21
Utility
Serotonin 5-HT2B Inhibitory Compounds
26 May 22
The compounds of the invention, as described herein, are novel serotonin 5-HT2B antagonists useful for the treatment of myxomatous mitral valve degeneration (MMVD), congestive heart failure (CHF), and/or asymptomatic heart failure in animals, preferably canine.
Richard Andrew Ewin, Govindan Subramanian, Jinxia (Nancy) Deng
Filed: 26 Mar 20
Utility
Internal Teat Sealants and Their Use In the Prevention of Bovine Mastitis In the Dry Cowb
5 May 22
An intramammary syringe contains a seal formulation for forming a physical barrier in the teat canal of a non-human animal.
Brendan Gerard Smith
Filed: 20 Dec 21
Utility
Multivalent Live-attenuated Influenza Vaccine for Prevention and Control of Equine Influenza Virus (EIV) in Horses
5 May 22
The present invention provides compositions and methods related to equine live-attenuated influenza vaccines.
Luis Martinez-Sobrido, Thomas Chambers, Kendall Wayne King
Filed: 27 Feb 20
Utility
Ready-to-use Injectable Formulations
28 Apr 22
The invention describes a ready-to-use injectable cephalosporin composition with reasonable viscosity, resuspendability, and syringeability attributes for injection as an antibiotic for animals.
Vijaya Bharti Joshi, Laibin Luo, Todd P. Foster
Filed: 5 Mar 20
Utility
INTERLEUKIN-31 Monoclonal Antibodies for Veterinary Use
28 Apr 22
A monoclonal antibody, or antigen-binding portion thereof is provided that specifically binds to a region on a mammalian IL-31 protein involved with interaction of the IL-31 protein with its co-receptor, wherein the binding of said antibody to said region is impacted by mutations in a 15H05 epitope binding region selected from: a region between about amino acid residues 124 and 135 of a feline IL-31 sequence represented by SEQ ID NO: 157 (Feline_IL31_wildtype); a region between about amino acid residues 124 and 135 of a canine IL-31 sequence represented by SEQ ID NO: 155 (Canine_IL31); and a region between about amino acid residues 118 and 129 of an equine IL-31 sequence represented by SEQ ID NO: 165 (Equine_IL31).
Gary Francis Bammert, Steven Alan Dunham, Sebastian C. J. Steiniger
Filed: 7 Jan 22
Utility
Anti-tgfb Antibodies and Therapeutic Uses Thereof
21 Apr 22
The present disclosure encompasses novel anti-TGFβ antibodies, antigen binding proteins and polynucleotides encoding the same.
Lisa Marie BERGERON, Gary F. Bammert, Henry Luis Campos, Sandra Ann Marie Lightle, Catherine J. Strietzel
Filed: 7 Jun 21
Utility
Fish Handling Apparatus and Associated Method
24 Mar 22
A fish handling apparatus comprises a supply arrangement arranged to supply a plurality of fish and a receiving arrangement arranged to receive and distribute a single fish of the plurality of fish.
Johan Odd Moflag
Filed: 23 Sep 21